NBIX•benzinga•
HC Wainwright & Co. Maintains Buy on Neurocrine Biosciences, Lowers Price Target to $168
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 22, 2025 by benzinga